O	0	10	Regulation	Regulation	NN	B-NP
O	11	13	of	of	IN	B-PP
O	14	22	glucosyl	glucosyl	NN	B-NP
O	22	23	-	-	HYPH	B-NP
O	24	27	and	and	CC	I-NP
O	28	48	fructosyltransferase	fructosyltransferase	NN	I-NP
O	49	58	synthesis	synthesis	NN	I-NP
O	59	61	by	by	IN	B-PP
O	62	72	continuous	continuous	JJ	B-NP
B-Cell	73	81	cultures	culture	NNS	I-NP
O	82	84	of	of	IN	B-PP
O	85	98	Streptococcus	Streptococcus	NNP	B-NP
O	99	105	mutans	mutan	NNS	I-NP
O	105	106	.	.	.	O

O	107	120	Streptococcus	Streptococcus	NN	B-NP
O	121	127	mutans	mutan	NNS	I-NP
B-Cell	128	135	strains	strain	NNS	I-NP
O	136	144	Ingbritt	Ingbritt	NNP	I-NP
O	144	145	,	,	,	O
O	146	149	and	and	CC	O
O	150	153	its	its	PRP$	B-NP
O	154	164	derivative	derivative	JJ	I-NP
O	165	167	B7	B7	NN	I-NP
O	168	173	which	which	WDT	B-NP
O	174	177	had	have	VBD	B-VP
O	178	182	been	be	VBN	I-VP
O	183	191	passaged	passage	VBN	I-VP
O	192	199	through	through	IN	B-PP
O	200	207	monkeys	monkey	NNS	B-NP
O	207	208	,	,	,	O
O	209	213	have	have	VBP	B-VP
O	214	218	been	be	VBN	I-VP
O	219	223	used	use	VBN	I-VP
O	224	226	to	to	TO	I-VP
O	227	238	investigate	investigate	VB	I-VP
O	239	242	how	how	WRB	B-ADVP
O	243	246	the	the	DT	B-NP
O	247	256	synthesis	synthesis	NN	I-NP
O	257	259	of	of	IN	B-PP
B-Immaterial_anatomical_entity	260	273	extracellular	extracellular	JJ	B-NP
O	274	282	glucosyl	glucosyl	NN	I-NP
O	282	283	-	-	HYPH	B-ADJP
O	284	287	and	and	CC	O
O	288	309	fructosyltransferases	fructosyltransferas	NNS	B-NP
O	310	312	is	be	VBZ	B-VP
O	313	322	regulated	regulate	VBN	I-VP
O	322	323	.	.	.	O

O	324	327	The	The	DT	B-NP
O	328	332	most	most	RBS	I-NP
O	333	339	active	active	JJ	I-NP
O	340	346	enzyme	enzyme	NN	I-NP
O	347	351	from	from	IN	B-PP
O	352	358	carbon	carbon	NN	B-NP
O	358	359	-	-	HYPH	B-ADVP
O	359	366	limited	limit	VBN	B-NP
O	367	377	continuous	continuous	JJ	I-NP
B-Cell	378	386	cultures	culture	NNS	I-NP
O	387	390	was	be	VBD	B-VP
O	391	392	a	a	DT	B-NP
O	393	413	fructosyltransferase	fructosyltransferase	NN	I-NP
O	413	414	;	;	:	O
O	415	422	enzymes	enzyme	NNS	B-NP
O	423	433	catalysing	catalyse	VBG	B-VP
O	434	437	the	the	DT	B-NP
O	438	447	formation	formation	NN	I-NP
O	448	450	of	of	IN	B-PP
O	451	456	water	water	NN	B-NP
O	456	457	-	-	HYPH	B-NP
O	457	466	insoluble	insoluble	JJ	I-NP
O	467	474	glucans	glucan	NNS	I-NP
O	475	479	from	from	IN	B-PP
O	480	487	sucrose	sucrose	NN	B-NP
O	488	492	were	be	VBD	B-VP
O	493	503	relatively	relatively	RB	B-ADJP
O	504	512	inactive	inactive	JJ	I-ADJP
O	512	513	.	.	.	O

O	514	528	Dextransucrase	Dextransucrase	NN	B-NP
O	529	530	(	(	(	O
O	530	532	EC	EC	NN	B-NP
O	533	534	2	2	CD	I-NP
O	534	535	.	.	.	O
O	535	536	4	4	CD	B-NP
O	536	537	.	.	.	O
O	537	538	1	1	CD	B-NP
O	538	539	.	.	.	I-NP
O	539	540	5	5	CD	I-NP
O	540	541	)	)	)	O
O	541	542	,	,	,	O
O	543	548	which	which	WDT	B-NP
O	549	558	catalyses	catalyse	VBZ	B-VP
O	559	566	soluble	soluble	JJ	B-NP
O	567	573	glucan	glucan	NN	I-NP
O	574	583	synthesis	synthesis	NN	I-NP
O	583	584	,	,	,	O
O	585	588	was	be	VBD	B-VP
O	589	593	most	most	RBS	B-ADJP
O	594	600	active	active	JJ	I-ADJP
O	601	603	in	in	IN	B-PP
O	604	607	the	the	DT	B-NP
B-Organism_substance	608	619	supernatant	supernatant	JJ	I-NP
O	620	625	fluid	fluid	NN	I-NP
O	626	630	from	from	IN	B-PP
B-Cell	631	639	cultures	culture	NNS	B-NP
O	640	645	grown	grow	VBN	B-VP
O	646	650	with	with	IN	B-PP
O	651	657	excess	excess	JJ	B-NP
O	658	665	glucose	glucose	NN	I-NP
O	665	666	,	,	,	I-NP
O	667	675	fructose	fructose	NN	I-NP
O	676	678	or	or	CC	I-NP
O	679	686	sucrose	sucrose	NN	I-NP
O	686	687	,	,	,	O
O	688	691	but	but	CC	O
O	692	696	full	full	JJ	B-NP
O	697	705	activity	activity	NN	I-NP
O	706	709	was	be	VBD	B-VP
O	710	718	detected	detect	VBN	I-VP
O	719	723	only	only	RB	B-ADVP
O	724	728	when	when	WRB	I-ADVP
O	729	732	the	the	DT	B-NP
O	733	739	enzyme	enzyme	NN	I-NP
O	740	743	was	be	VBD	B-VP
O	744	753	incubated	incubate	VBN	I-VP
O	754	758	with	with	IN	B-PP
O	759	763	both	both	CC	O
O	764	771	sucrose	sucrose	NN	B-NP
O	772	775	and	and	CC	I-NP
O	776	783	dextran	dextran	NN	I-NP
O	783	784	.	.	.	O

O	785	791	Little	Little	JJ	B-NP
O	792	806	dextransucrase	dextransucrase	NN	I-NP
O	807	815	activity	activity	NN	I-NP
O	816	819	was	be	VBD	B-VP
O	820	828	detected	detect	VBN	I-VP
O	829	831	in	in	IN	B-PP
O	832	838	carbon	carbon	NN	B-NP
O	838	839	-	-	HYPH	B-NP
O	839	846	limited	limit	VBN	I-NP
B-Cell	847	855	cultures	culture	NNS	I-NP
O	855	856	.	.	.	O

O	857	859	It	It	PRP	B-NP
O	860	862	is	be	VBZ	B-VP
O	863	872	concluded	conclude	VBN	I-VP
O	873	877	that	that	IN	B-SBAR
O	878	886	glucosyl	glucosyl	NN	B-NP
O	886	887	-	-	HYPH	B-NP
O	888	891	and	and	CC	O
O	892	913	fructosyltransferases	fructosyltransferas	NNS	B-NP
O	914	917	are	be	VBP	B-VP
O	918	930	constitutive	constitutive	JJ	B-NP
O	931	938	enzymes	enzyme	NNS	I-NP
O	939	941	in	in	IN	B-SBAR
O	942	946	that	that	IN	I-SBAR
O	947	951	they	they	PRP	B-NP
O	952	955	are	be	VBP	B-VP
O	956	967	synthesized	synthesize	VBN	I-VP
O	968	970	at	at	IN	B-PP
O	971	978	similar	similar	JJ	B-NP
O	979	984	rates	rate	NNS	I-NP
O	985	991	during	during	IN	B-PP
O	992	998	growth	growth	NN	B-NP
O	999	1003	with	with	IN	B-PP
O	1004	1006	an	an	DT	B-NP
O	1007	1013	excess	excess	NN	I-NP
O	1014	1016	of	of	IN	B-PP
O	1017	1020	the	the	DT	B-NP
O	1021	1030	substrate	substrate	NN	I-NP
O	1031	1033	or	or	CC	B-PP
O	1034	1036	of	of	IN	B-PP
O	1037	1040	the	the	DT	B-NP
O	1041	1049	products	product	NNS	I-NP
O	1050	1052	of	of	IN	B-PP
O	1053	1056	the	the	DT	B-NP
O	1057	1066	reactions	reaction	NNS	I-NP
O	1067	1072	which	which	WDT	B-NP
O	1073	1077	they	they	PRP	B-NP
O	1078	1086	catalyse	catalyse	VBP	B-VP
O	1086	1087	.	.	.	O

O	1088	1096	Although	Although	IN	B-SBAR
O	1097	1100	the	the	DT	B-NP
O	1101	1109	Ingbritt	Ingbritt	NNP	I-NP
B-Cell	1110	1116	strain	strain	NN	I-NP
O	1117	1120	was	be	VBD	B-VP
O	1121	1131	originally	originally	RB	I-VP
O	1132	1140	isolated	isolate	VBN	I-VP
O	1141	1145	from	from	IN	B-PP
O	1146	1147	a	a	DT	B-NP
B-Pathological_formation	1148	1155	carious	carious	JJ	I-NP
I-Pathological_formation	1156	1162	lesion	lesion	NN	I-NP
O	1162	1163	,	,	,	O
O	1164	1166	it	it	PRP	B-NP
O	1167	1169	is	be	VBZ	B-VP
O	1170	1173	now	now	RB	B-ADVP
O	1174	1175	a	a	DT	B-NP
O	1176	1180	poor	poor	JJ	I-NP
O	1181	1187	source	source	NN	I-NP
O	1188	1190	of	of	IN	B-PP
O	1191	1210	glucosyltransferase	glucosyltransferase	NN	B-NP
O	1211	1219	activity	activity	NN	I-NP
O	1219	1220	.	.	.	O

O	1221	1241	Glucosyltransferases	Glucosyltransferas	NNS	B-NP
O	1242	1246	were	be	VBD	B-VP
O	1247	1256	extremely	extremely	RB	B-ADJP
O	1257	1263	active	active	JJ	I-ADJP
O	1264	1266	in	in	IN	B-PP
B-Cell	1267	1275	cultures	culture	NNS	B-NP
O	1276	1278	of	of	IN	B-PP
O	1279	1280	a	a	DT	B-NP
O	1281	1287	recent	recent	JJ	I-NP
O	1288	1296	clinical	clinical	JJ	I-NP
O	1297	1304	isolate	isolate	NN	I-NP
O	1304	1305	,	,	,	O
B-Cell	1306	1312	strain	strain	NN	B-NP
I-Cell	1313	1317	3209	3209	CD	I-NP
O	1317	1318	,	,	,	O
O	1319	1322	and	and	CC	O
O	1323	1327	were	be	VBD	B-VP
O	1328	1338	apparently	apparently	RB	I-VP
O	1339	1346	induced	induce	VBN	I-VP
O	1347	1353	during	during	IN	B-PP
O	1354	1360	growth	growth	NN	B-NP
O	1361	1365	with	with	IN	B-PP
O	1366	1372	excess	excess	JJ	B-NP
O	1373	1380	glucose	glucose	NN	I-NP
O	1380	1381	.	.	.	O

